vs

Side-by-side financial comparison of AerSale Corp (ASLE) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.

AerSale Corp is the larger business by last-quarter revenue ($90.9M vs $47.7M, roughly 1.9× IRONWOOD PHARMACEUTICALS INC). AerSale Corp runs the higher net margin — 5.9% vs -4.8%, a 10.7% gap on every dollar of revenue. On growth, AerSale Corp posted the faster year-over-year revenue change (-4.0% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $9.8M). Over the past eight quarters, AerSale Corp's revenue compounded faster (0.2% CAGR vs -20.2%).

AerSale, Inc. is a Doral, Florida-based global supplier of aftermarket commercial jet aircraft, engines, used materials, and aeronautical engineering services to passenger and cargo airlines, government, multinational original equipment manufacturers, and independent MROs. AerSale is a member of the Aircraft Fleet Recycling Association.

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

ASLE vs IRWD — Head-to-Head

Bigger by revenue
ASLE
ASLE
1.9× larger
ASLE
$90.9M
$47.7M
IRWD
Growing faster (revenue YoY)
ASLE
ASLE
+43.3% gap
ASLE
-4.0%
-47.3%
IRWD
Higher net margin
ASLE
ASLE
10.7% more per $
ASLE
5.9%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$64.8M more FCF
IRWD
$74.6M
$9.8M
ASLE
Faster 2-yr revenue CAGR
ASLE
ASLE
Annualised
ASLE
0.2%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASLE
ASLE
IRWD
IRWD
Revenue
$90.9M
$47.7M
Net Profit
$5.4M
$-2.3M
Gross Margin
34.1%
Operating Margin
7.8%
14.3%
Net Margin
5.9%
-4.8%
Revenue YoY
-4.0%
-47.3%
Net Profit YoY
99.7%
-200.9%
EPS (diluted)
$0.10
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASLE
ASLE
IRWD
IRWD
Q4 25
$90.9M
$47.7M
Q3 25
$71.2M
$122.1M
Q2 25
$107.4M
$85.2M
Q1 25
$65.8M
$41.1M
Q4 24
$94.7M
$90.5M
Q3 24
$82.7M
$91.6M
Q2 24
$77.1M
$94.4M
Q1 24
$90.5M
$74.9M
Net Profit
ASLE
ASLE
IRWD
IRWD
Q4 25
$5.4M
$-2.3M
Q3 25
$-120.0K
$40.1M
Q2 25
$8.6M
$23.6M
Q1 25
$-5.3M
$-37.4M
Q4 24
$2.7M
$2.3M
Q3 24
$509.0K
$3.6M
Q2 24
$-3.6M
$-860.0K
Q1 24
$6.3M
$-4.2M
Gross Margin
ASLE
ASLE
IRWD
IRWD
Q4 25
34.1%
Q3 25
30.2%
Q2 25
32.9%
Q1 25
27.3%
Q4 24
31.4%
Q3 24
28.6%
Q2 24
28.2%
Q1 24
31.8%
Operating Margin
ASLE
ASLE
IRWD
IRWD
Q4 25
7.8%
14.3%
Q3 25
4.0%
61.8%
Q2 25
11.7%
53.2%
Q1 25
-10.1%
-70.7%
Q4 24
5.2%
34.8%
Q3 24
2.4%
28.0%
Q2 24
-2.4%
26.5%
Q1 24
5.2%
14.7%
Net Margin
ASLE
ASLE
IRWD
IRWD
Q4 25
5.9%
-4.8%
Q3 25
-0.2%
32.8%
Q2 25
8.0%
27.7%
Q1 25
-8.0%
-90.9%
Q4 24
2.9%
2.5%
Q3 24
0.6%
4.0%
Q2 24
-4.7%
-0.9%
Q1 24
6.9%
-5.6%
EPS (diluted)
ASLE
ASLE
IRWD
IRWD
Q4 25
$0.10
$0.01
Q3 25
$0.00
$0.23
Q2 25
$0.18
$0.14
Q1 25
$-0.10
$-0.23
Q4 24
$0.05
$0.03
Q3 24
$0.01
$0.02
Q2 24
$-0.07
$-0.01
Q1 24
$0.12
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASLE
ASLE
IRWD
IRWD
Cash + ST InvestmentsLiquidity on hand
$4.4M
$215.5M
Total DebtLower is stronger
$1.3M
Stockholders' EquityBook value
$424.4M
$-261.8M
Total Assets
$640.5M
$396.9M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASLE
ASLE
IRWD
IRWD
Q4 25
$4.4M
$215.5M
Q3 25
$5.3M
$140.4M
Q2 25
$5.7M
$92.9M
Q1 25
$4.7M
$108.5M
Q4 24
$4.7M
$88.6M
Q3 24
$9.8M
$88.2M
Q2 24
$4.3M
$105.5M
Q1 24
$2.6M
$121.5M
Total Debt
ASLE
ASLE
IRWD
IRWD
Q4 25
$1.3M
Q3 25
$1.5M
$199.5M
Q2 25
$907.0K
$199.3M
Q1 25
$1.1M
$199.2M
Q4 24
$1.2M
$199.0M
Q3 24
$376.0K
$198.8M
Q2 24
$522.0K
$198.6M
Q1 24
$3.5M
$398.3M
Stockholders' Equity
ASLE
ASLE
IRWD
IRWD
Q4 25
$424.4M
$-261.8M
Q3 25
$417.1M
$-264.2M
Q2 25
$415.9M
$-308.2M
Q1 25
$406.5M
$-334.1M
Q4 24
$455.6M
$-301.3M
Q3 24
$451.5M
$-311.3M
Q2 24
$449.8M
$-321.7M
Q1 24
$452.0M
$-330.5M
Total Assets
ASLE
ASLE
IRWD
IRWD
Q4 25
$640.5M
$396.9M
Q3 25
$646.3M
$396.1M
Q2 25
$646.7M
$342.9M
Q1 25
$646.1M
$327.2M
Q4 24
$604.7M
$350.9M
Q3 24
$601.5M
$389.5M
Q2 24
$598.7M
$395.6M
Q1 24
$571.7M
$438.8M
Debt / Equity
ASLE
ASLE
IRWD
IRWD
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASLE
ASLE
IRWD
IRWD
Operating Cash FlowLast quarter
$11.4M
$74.6M
Free Cash FlowOCF − Capex
$9.8M
$74.6M
FCF MarginFCF / Revenue
10.8%
156.3%
Capex IntensityCapex / Revenue
1.7%
0.0%
Cash ConversionOCF / Net Profit
2.11×
TTM Free Cash FlowTrailing 4 quarters
$-29.1M
$127.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASLE
ASLE
IRWD
IRWD
Q4 25
$11.4M
$74.6M
Q3 25
$-8.9M
$47.6M
Q2 25
$19.8M
$-15.1M
Q1 25
$-45.2M
$20.0M
Q4 24
$37.5M
$15.2M
Q3 24
$10.4M
$9.9M
Q2 24
$-15.3M
$33.5M
Q1 24
$-21.5M
$45.0M
Free Cash Flow
ASLE
ASLE
IRWD
IRWD
Q4 25
$9.8M
$74.6M
Q3 25
$-9.8M
$47.6M
Q2 25
$18.6M
$-15.1M
Q1 25
$-47.6M
$19.9M
Q4 24
$32.3M
Q3 24
$8.9M
$9.9M
Q2 24
$-18.9M
$33.4M
Q1 24
$-25.0M
$44.9M
FCF Margin
ASLE
ASLE
IRWD
IRWD
Q4 25
10.8%
156.3%
Q3 25
-13.8%
39.0%
Q2 25
17.3%
-17.7%
Q1 25
-72.4%
48.4%
Q4 24
34.0%
Q3 24
10.7%
10.8%
Q2 24
-24.6%
35.4%
Q1 24
-27.7%
60.0%
Capex Intensity
ASLE
ASLE
IRWD
IRWD
Q4 25
1.7%
0.0%
Q3 25
1.3%
0.0%
Q2 25
1.1%
0.0%
Q1 25
3.7%
0.1%
Q4 24
5.6%
0.0%
Q3 24
1.9%
0.0%
Q2 24
4.7%
0.1%
Q1 24
3.9%
0.1%
Cash Conversion
ASLE
ASLE
IRWD
IRWD
Q4 25
2.11×
Q3 25
1.19×
Q2 25
2.31×
-0.64×
Q1 25
Q4 24
13.89×
6.74×
Q3 24
20.52×
2.71×
Q2 24
Q1 24
-3.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASLE
ASLE

Products$57.8M64%
Maintenance$23.2M26%
Leasing Arrangements$9.9M11%

IRWD
IRWD

Segment breakdown not available.

Related Comparisons